- Home
- QH vs NKTR Comparison
QH vs NKTR Comparison
Compare QH & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QH
- NKTR
- Stock Information
- Founded
- QH 2012
- NKTR 1990
- Country
- QH China
- NKTR United States
- Employees
- QH N/A
- NKTR N/A
- Industry
- QH Business Services
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- QH Consumer Discretionary
- NKTR Health Care
- Exchange
- QH Nasdaq
- NKTR Nasdaq
- Market Cap
- QH 104.9M
- NKTR 108.3M
- IPO Year
- QH 2020
- NKTR 1994
- Fundamental
- Price
- QH $1.30
- NKTR $24.25
- Analyst Decision
- QH
- NKTR Strong Buy
- Analyst Count
- QH 0
- NKTR 6
- Target Price
- QH N/A
- NKTR $81.67
- AVG Volume (30 Days)
- QH 22.2K
- NKTR 4.8M
- Earning Date
- QH 08-27-2025
- NKTR 08-07-2025
- Dividend Yield
- QH N/A
- NKTR N/A
- EPS Growth
- QH N/A
- NKTR N/A
- EPS
- QH 0.01
- NKTR N/A
- Revenue
- QH $417,431,053.00
- NKTR $87,248,000.00
- Revenue This Year
- QH N/A
- NKTR N/A
- Revenue Next Year
- QH N/A
- NKTR N/A
- P/E Ratio
- QH $144.82
- NKTR N/A
- Revenue Growth
- QH N/A
- NKTR N/A
- 52 Week Low
- QH $0.25
- NKTR $6.48
- 52 Week High
- QH $2.27
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- QH 54.65
- NKTR 63.40
- Support Level
- QH $1.16
- NKTR $21.87
- Resistance Level
- QH $1.45
- NKTR $26.59
- Average True Range (ATR)
- QH 0.09
- NKTR 4.14
- MACD
- QH 0.01
- NKTR 0.01
- Stochastic Oscillator
- QH 42.23
- NKTR 54.77
About QH Quhuo Limited American Depository Shares
Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.